Intellia TL-2002-OBS-401 - A Patient Interview Study / NIS

• Research type

  Research Study

• Full title

  ITL-2002-OBS-401: Lived Experiences of Clinical Trial Participants Treated with NTLA-2002 – A Patient Interview Study

• IRAS ID

  359274

• Contact name

  Padmalal Gurugama

• Contact email

  padmalal.gurugama@nhs.net

• Sponsor organisation

  Intellia Therapeutics Inc.

• Duration of Study in the UK

  0 years, 2 months, 28 days

• Research summary

  Prior participants in Intellia’s clinical trial for a new gene-editing therapy to treat hereditary angioedema (HAE) will be interviewed to better understand their experience with this treatment and how it has affected their lives.

• REC name

  London - Stanmore Research Ethics Committee

• REC reference

  25/PR/0915

• Date of REC Opinion

  11 Sep 2025

• REC opinion

  Further Information Favourable Opinion